ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Arab American University (Palestine)
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Samsung Medical Center